Argüelles-Grande C, Leon F, Matilla J, Domínguez J, Montero J
Dept of Primary Health Care, Ramón y Cajal Hospital, Madrid, Spain.
Scand J Gastroenterol. 2002 Sep;37(9):1111-3. doi: 10.1080/003655202320378347.
Leukemoid reactions (LRs) are rare in alcoholic hepatitis (AH), but they are a sign of poor prognosis. The treatment of AH with corticosteroids is controversial, though several reports suggest that these should be used in severe cases of AH. We report a case of AH-associated LRs that presented with an increase of the serum concentrations of the proinflammatory cytokines interleukin (IL)-18 (an initiator of inflammation) and IL-1beta (likely responsible for the neutrophilia of the LRs). These findings provided a pathogenic indication for the use of corticosteroids (that block the transcription of IL-1beta), and this approach achieved a clinical and analytical recovery in our patient. This pathogenic mechanism might also underlie other cases of LRs and other complications of AH, thus providing a rationale for the benefits of corticotherapy in these rare but severe conditions.
类白血病反应(LRs)在酒精性肝炎(AH)中较为罕见,但却是预后不良的标志。尽管有几份报告表明应在严重的AH病例中使用皮质类固醇进行治疗,但用皮质类固醇治疗AH仍存在争议。我们报告了一例与AH相关的LRs病例,该病例表现为促炎细胞因子白细胞介素(IL)-18(炎症启动因子)和IL-1β(可能是LRs中性粒细胞增多的原因)血清浓度升高。这些发现为使用皮质类固醇(可阻断IL-1β转录)提供了致病依据,并且这种方法使我们的患者在临床和分析方面均得以康复。这种致病机制可能也是其他LRs病例以及AH其他并发症的基础,从而为在这些罕见但严重的情况下进行皮质激素治疗的益处提供了理论依据。